Research
Structure-guided design of a dual-antigen mRNA vaccine conferring broad protection against Henipaviruses
The Brief
- Researchers developed a structure-guided mRNA vaccine that combines two Nipah virus proteins.
- All vaccinated hamsters survived challenge with Nipah-Malaysia, Nipah-Bangladesh or Hendra virus.
- The study was published online in Nature Communications on 19 November 2026.
Why it matters
The results show one vaccine candidate protecting animals against several henipaviruses, which is relevant to preparing countermeasures for these high-consequence pathogens. The findings come from hamster challenge studies, so they do not by themselves establish protection in humans.
Who’s affected
- vaccine researchers
- public health planners working on emerging zoonotic viruses
- #mrna vaccine
- #nipah virus
- #henipavirus
- #hendra virus
- #vaccine design
Nature Communications, Published online: 19 November 2026; doi:10.1038/s41467-026-79459-9 The authors develop a structure-guided mRNA vaccine combining two Nipah virus proteins. All vaccinated hamsters survive challenge with Nipah-Malaysia, Nipah-Bangladesh or Hendra virus, with…